Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease-Reference-Cited by-同舟云学术

Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease

Published:2022-05-21 Issue:7 Volume:37 Page:1535-1541
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Kim Ryul¹^ORCID,Kim Han‐Joon²^ORCID,Shin Jung Hwan²^ORCID,Lee Chan Young³,Jeon Seung Ho⁴,Jeon Beomseok²

Affiliation:

1. Department of Neurology Inha University Hospital, Inha University College of Medicine Incheon South Korea

2. Department of Neurology and Movement Disorder Center Seoul National University Hospital, Seoul National University College of Medicine Seoul South Korea

3. Department of Neurology School of Medicine, Ewha Womans University Mokdong Hospital Seoul South Korea

4. Eco Fineday Neurology Clinic Jeonju South Korea

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29056

Reference32 articles.

1. Non-motor symptoms of Parkinson's disease: diagnosis and management

2. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

3. Update of the MDS research criteria for prodromal Parkinson's disease

4. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

5. Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoaminergic degeneration, cognition, and autonomic symptom trajectory in early Parkinson's disease;Parkinsonism & Related Disorders;2024-10

2. Associations Between Neuropsychiatric Symptoms and Inflammation in Neurodegenerative Dementia: A Systematic Review;Journal of Inflammation Research;2024-09

3. Alpha Synuclein Toxicity and Non-Motor Parkinson’s;Cells;2024-07-27

4. Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation;Parkinsonism & Related Disorders;2024-05

5. How Lifetime Evolution of Parkinson’s Disease Could Shape Clinical Trial Design: A Shared Patient–Clinician Viewpoint;Brain Sciences;2024-04-03